(Q36613180)

15 August 2017

Activity of 5-chloro-pyrazinamide in mice infected with Mycobacterium tuberculosis or Mycobacterium bovis (English)

1 reference

Mycobacterium tuberculosis

15 August 2017

1 reference

Mycobacterium bovis

1 reference

10

Jacques H Grosset

1 reference

15 August 2017

5

Eric L Nuermberger

1 reference

15 August 2017

Zahoor Ahmad

1

1 reference

15 August 2017

Sandeep Tyagi

2

1 reference

15 August 2017

Austin Minkowsk

3

1 reference

15 August 2017

Deepak Almeida

4

1 reference

15 August 2017

Kaitlin M Peck

6

1 reference

15 August 2017

John T Welch

7

1 reference

15 August 2017

Anthony S Baughn

8

1 reference

15 August 2017

Williams R Jacobs

9

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 November 2012

1 reference

Indian Journal of Medical Research

15 August 2017

1 reference

15 August 2017

136

1 reference

15 August 2017

808-814

1 reference

15 August 2017

5

1 reference

Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig.

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573602

Paradoxical effect of isoniazid on the activity of rifampin-pyrazinamide combination in a mouse model of tuberculosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573602

Promising antituberculosis activity of the oxazolidinone PNU-100480 relative to that of linezolid in a murine model

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573602

Bactericidal activity of the nitroimidazopyran PA-824 in a murine model of tuberculosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573602

Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573602

The curious characteristics of pyrazinamide: a review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573602

Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573602

In vitro antimycobacterial activity of 5-chloropyrazinamide

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573602

Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573602

Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573602

Pyrazinamide susceptibility and amidase activity of tubercle bacilli

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573602

The role of pyrazinamide in tuberculosis chemotherapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573602

Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573602

Antimycobacterial activity of a series of pyrazinoic acid esters

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573602

The sterilizing value of rifampicin and pyrazinamide in experimental short-course chemotherapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573602

Pyrazinoic acid esters with broad spectrum in vitro antimycobacterial activity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573602

Enhancement of the antituberculosis activity of weak acids by inhibitors of energy metabolism but not by anaerobiosis suggests that weak acids act differently from the front-line tuberculosis drug pyrazinamide

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573602

Anaerobic incubation conditions enhance pyrazinamide activity against Mycobacterium tuberculosis

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573602

Nicotinamidase in Mycobacteria: A Method for Distinguishing Bovine Type Tubercle Bacilli from other Mycobacteria

20 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23287128

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

1 reference

15 August 2017

1 reference